Chronic hypertension causes hypertensive nephrosclerosis and raises cystatin C and BUN.

The physiological link between chronic hypertension and the deterioration of renal function is well-established, particularly in older populations where hypertensive nephrosclerosis acts as a primary driver of structural and functional decline.

Clinical and Structural Evidence

Chronic hypertension induces a cascade of microvascular damage known as hypertensive nephrosclerosis. In a 74-year-old male, this process is particularly impactful as it layers upon natural age-related nephron loss.

• Vascular Damage: Sustained high intraluminal pressure causes hyaline arteriolosclerosis (thickening of arteriolar walls) and myointimal hyperplasia. This leads to luminal narrowing, chronic ischemia, and subsequent atrophy of the renal parenchyma.
• Glomerular Impact: Glomerular capillary hypertension results in endothelial injury and podocyte loss. This barotrauma triggers focal or global glomerulosclerosis—scarring that permanently disables the kidney's individual filtration units.
• Filtration Reserve: The loss of functional nephrons directly reduces the kidney's filtration reserve. As some nephrons fail, the remaining healthy units undergo "hyperfiltration" to compensate, which eventually leads to further injury and an accelerated decline in total glomerular filtration rate (GFR).

Mechanistic Explanations

The progression of hypertensive kidney disease involves both hemodynamic stress and molecular signaling pathways.

• RAAS Activation: High pressure triggers the renin-angiotensin-aldosterone system (RAAS), which promotes the release of pro-fibrotic cytokines like TGF-beta. These cytokines drive the deposition of extracellular matrix in the glomeruli and interstitium, solidifying the transition from high blood pressure to permanent scarring.
• Biomarker Elevation: As the GFR falls due to nephron loss, serum levels of Cystatin C and Blood Urea Nitrogen (BUN) rise.
  • Cystatin C: This low-molecular-weight protein is produced at a constant rate and is not secreted by the tubules. Its rise is almost purely a function of reduced glomerular filtration, making it a highly sensitive marker in older adults with reduced muscle mass.
  • BUN: While BUN increases as filtration decreases, it is also influenced by the slowed flow of filtrate through the nephron, which allows for increased passive reabsorption of urea into the blood, compounding its elevation beyond simple filtration failure.

Bottom line

Chronic hypertension is a definitive cause of hypertensive nephrosclerosis, which accelerates the loss of renal filtration reserve. This decline is reliably indicated by elevations in Cystatin C and BUN, with Cystatin C providing a more sensitive metric for older patients undergoing hypertensive renal remodeling.